Xuanyuan Li
State Key Laboratory Of Druggability Evaluation And Systematic Translational Medicine, Key Laboratory Of Cancer Prevention And Therapy
Tianjin, 300060, China
Tianjin, 300060, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
BAP1 and UTX are dispensable for transcription-driven Polycomb erasure but essential for enhancer establishment.
Journal: The Journal of biological chemistry
Published: May 01, 2026
Erratum: A CRISPR/Cas9 library screening identifies CARM1 as a critical inhibitor of ferroptosis in hepatocellular carcinoma cells.
Journal: Molecular therapy. Nucleic acids
Published: April 24, 2025
USP22 promotes the proliferation and Sorafenib resistance of hepatocellular carcinoma cells via its deubiquitinase activity.
Journal: Clinical and translational medicine
Published: December 03, 2024
Targeted disruption of PRC1.1 complex enhances bone remodeling.
Journal: Nature communications
Published: November 14, 2024
CBX4 plays a bidirectional role in transcriptional regulation and lung adenocarcinoma progression.
Journal: Cell death & disease
Published: January 13, 2024
CBX8 promotes lung adenocarcinoma growth and metastasis through transcriptional repression of CDKN2C and SCEL.
Journal: Journal of cellular physiology
Published: June 16, 2023
A CRISPR-Cas9 library screening identifies CARM1 as a critical inhibitor of ferroptosis in hepatocellular carcinoma cells.
Journal: Molecular therapy. Nucleic acids
Published: June 13, 2023
Integrated analysis of genes encoding ATP-dependent chromatin remodellers identifies CHD7 as a potential target for colorectal cancer therapy.
Journal: Clinical and translational medicine
Published: March 21, 2022
CBX8 Together with SET Facilitates Ovarian Carcinoma Growth and Metastasis by Suppressing the Transcription of SUSD2.
Journal: Molecular cancer research : MCR
Published: February 18, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026